#real-world data

[rwatimes]

Toss Brings 30 Million Users Into the AI Data Economy in Partnership With Poseidon - Brave New Coin

Palo Alto, United States, 26th June 2026, Chainwire

➤ Poseidon and Toss are partnering to enable Toss's 30 million users to contribute real-world data for AI training and earn compensation. ➤ This initiative aims to address the growing demand for diverse, real-world data, which is crucial for the next generation of AI models. ➤ The partnership will launch in Korea, with plans for global expansion, focusing on verifiable data provenance and transparent user rewards.

[rwatimes]

AI Oracles for Smart Contracts: Intelligent Real-World Data On-Chain

Learn how AI oracles for smart contracts bring intelligent real-world data, predictions, and risk signals on-chain for adaptive Web3 automation.

➤ AI oracles are enhancing smart contracts by integrating intelligent real-world data, predictions, and risk signals on-chain, enabling more adaptive Web3 automation. ➤ These AI oracles process data using machine learning before delivering it to smart contracts, moving beyond simple data feeds to provide decision-ready intelligence for applications in DeFi, supply chain, and insurance. ➤ While offering significant potential, AI oracles also introduce challenges related to data quality, bias, explainability, security, and regulatory compliance, requiring careful design and best practices.

[rwatimes]

XYO Crypto Unveiled: A Deep Dive Into Blockchain Innovation

$XYO Network is one of the oldest and largest Decentralized Physical Infrastructure Networks (DePIN) in existence, running over 10 million nodes globally and collecting real-world data

➤ XYO Network is a prominent Decentralized Physical Infrastructure Network (DePIN) that collects and validates real-world data using a network of over 10 million nodes. ➤ The project has evolved significantly, launching its own Layer 1 blockchain, a dual-token economy, and achieving SEC Regulation A approval, positioning itself for AI and Web3 applications. ➤ While XYO offers unique advantages in data sovereignty and regulatory compliance, risks include a large circulating supply and the need for substantial revenue growth to justify price appreciation.

[rwatimes]

Formation Bio Associate Director, Real World Data Job Boston

➤ Formation Bio is hiring an Associate Director of Real World Data (RWD) Intelligence to lead RWD strategy and execution, focusing on data sourcing, harmonization, and delivery. ➤ The role involves building and maintaining scalable data infrastructure, managing vendor relationships, and applying AI/ML tools for data harmonization, particularly using OMOP CDM. ➤ Ideal candidates have extensive RWD experience in pharma/biotech, strong data engineering skills, and a deep understanding of biomedical ontologies and drug development use cases.

[segmed]

How to Build an AI Team In a Health Center: Experience in a LatAm Hospital - Dr. Martina Aineseder

Explore how AI-powered medical imaging and real-world data are transforming healthcare innovation. Learn how advanced data pipelines improve research efficiency, enable better insights, and accelerate precision medicine.

For more information visit: https://www.segmed.ai/

[segmed]

Accelerating Precision Health: Unlocking Real-World Imaging Data with Verily Pre and Segmed

Precision health depends on accessible, unified data. This session explores how integrating real-world imaging and multimodal datasets enables secure analysis, accelerates research, and bridges critical data gaps in healthcare and life sciences innovation.

[worldpharmatoday]

https://www.worldpharmatoday.com/press-releases/datma-launches-federated-biomarker-explorer-with-free-access-to-help-pharma-validate-real-world-data-coverage/

datma Launches Federated Biomarker Explorer with Free Access to Help Pharma Validate Real-World Data Coverage.

The Federated Biomarker Explorer eases data feasibility by allowing pharma teams to assess biomarker presence early without integration or IT support needed. For info visit us https://www.worldpharmatoday.com/ ,  For more info: [email protected]  

[theconcinnitycompany]

Spotlight on Immunology: Why Automation Is the New Cure for Immune Disorder Trials

Discover how automation is revolutionizing immune disorder clinical trials. This blog explores its role in enhancing data accuracy, reducing delays, and improving outcomes in immunology research. Learn why automation is becoming essential in accelerating trial success and advancing patient-centric innovations.